A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)

NCT04762498 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Gout
Chronic Gout

Interventions

BIOLOGICAL: Pegloticase
DRUG: Methotrexate (MTX)

Sponsor

Amgen